Business context and reporting period
Filing identity warning: The request identifies Skye Bioscience, Inc., but the supplied filing is for Load Guard Logistics, Inc. This summary covers the supplied filing, not Skye Bioscience. It is a Form 10-K for the fiscal year ended October 31, 2013; it does not report standalone fourth-quarter results.
Load Guard is an early-stage trucking and logistics company operating through its Florida subsidiary. It hauls general freight and arranges transportation through independent contractors, relying substantially on freight brokers. Operations began in October 2012, so the year-over-year comparison is not for equivalent operating periods.
Financial results and liquidity
| Metric | Year ended October 31, 2013 | Year ended October 31, 2012 |
|---|---|---|
| Revenue | $339,926 | $16,243 |
| Operating income (loss) | $(7,242) | $4,117 |
| Net income (loss), financial statements | $(3,782) | $4,509 |
| Operating cash flow | $(14,495) | $1,928 |
| Cash at year-end | $52,186 | $26,404 |
- 2013 operating margin was approximately negative 2.1%; net margin was approximately negative 1.1%.
- Revenue comprised $290,265 of direct trucking revenue, $41,753 of brokerage income, and $7,907 of fuel surcharges.
- Current assets were $106,134 and current liabilities $62,317, yielding working capital of $43,817 and a current ratio of approximately 1.7.
- Current liabilities included $47,238 in related-party notes payable. The notes were described as due by March and June 2014; one carried no interest and the other an 8% rate.
- Financing cash flow was $78,393, including $48,600 from stock issuance. Investing cash use was $38,116.
Material changes, outlook, and risks
- Revenue increased sharply as operations began, but the company moved from 2012 net income to a 2013 net loss and used cash in operations.
- Management said cash and operating income were expected to meet needs for the next 12 months, while the financial-statement note says financing may be insufficient and identifies substantial doubt about the company’s ability to continue as a going concern. Management planned to seek equity financing and officer/director loans; no assurance was given that those plans would succeed.
- Two customers generated approximately 67.4% of 2013 revenue and accounted for 81.1% of receivables. The company also cited intense rate competition, fuel and maintenance cost sensitivity, seasonal freight patterns, and possible insurance and regulatory cost increases.
- The company reported ineffective disclosure controls and a material weakness in internal control over financial reporting due to inadequate segregation of duties. Management said it used additional analyses and post-closing procedures.
- The common stock was not quoted on the OTC Bulletin Board and had no present market, according to the filing. The company raised $23,800 from a share offering that closed November 1, 2013.
- The filing reports a $6,506 gain on an insurance claim and a $1,684 loss on equipment disposal in 2013.
Important facts for investors to verify
- Confirm the issuer: the supplied 10-K is for Load Guard Logistics, not Skye Bioscience.
- Reconcile the 2012 earnings comparison: MD&A reports net income of $4,755, while the audited statement reports $4,509 after a $246 tax provision.
- Review the independent auditor’s report: the supplied text describes a 2013 audit but includes opinion language referring to the 2012 financial statements. Verify the filed report and its going-concern discussion.
- Assess the company’s ability to refinance or repay related-party notes due in 2014, given negative operating cash flow and the going-concern disclosure.
- Check customer concentration, receivable collections, and the effectiveness of remediation for the disclosed control weakness.